Axis Securities initiates coverage on Max Healthcare with a buy rating and a target price of Rs 1,315, representing an 18% upside. The positive outlook is driven by projected revenue growth, improved occupancy rates, and strategic expansion. Max Healthcare's strong financial performance, including robust CFO generation and high EBITDA margin, further supports the bullish stance.
